Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    June 2022
  1. LIM H, Kim SE, Lee YH, Hwang YH, et al
    Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.
    Virology. 2022;573:118-123.
    PubMed     Abstract available


    May 2022
  2. KHAN K, Khan SA, Jalal K, Ul-Haq Z, et al
    Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Virology. 2022;572:28-43.
    PubMed     Abstract available


    April 2022
  3. NGUYEN NH, Nguyen PBT, Nguyen TQ, Do DT, et al
    Genotypic diversity of CSFV field strains: A silent risk reduces vaccination efficacy of CSFV vaccines in Vietnam.
    Virology. 2022;571:39-45.
    PubMed     Abstract available


  4. MI T, Wang T, Xu H, Sun P, et al
    Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants.
    Virology. 2022;569:56-63.
    PubMed     Abstract available


    February 2022
  5. CHEN X, Sun HY, Lee CY, Rostad CA, et al
    Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.
    Virology. 2022;569:44-55.
    PubMed     Abstract available


    January 2022
  6. MATSUYAMA-KATO A, Iseki H, Boodhoo N, Bavananthasivam J, et al
    Phenotypic characterization of gamma delta (gammadelta) T cells in chickens infected with or vaccinated against Marek's disease virus.
    Virology. 2022;568:115-125.
    PubMed     Abstract available


  7. ROSENGARTEN JF, Schatz S, Wolf T, Barbe S, et al
    Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.
    Virology. 2022;568:41-48.
    PubMed     Abstract available


    December 2021
  8. PARK BR, Subbiah J, Kim KH, Kwon YM, et al
    Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.
    Virology. 2021;566:143-152.
    PubMed     Abstract available


  9. KORNUTA CA, Cheuquepan F, Bidart JE, Soria I, et al
    TLR activation, immune response and viral protection elicited in cattle by a commercial vaccine against Bovine Herpesvirus-1.
    Virology. 2021;566:98-105.
    PubMed     Abstract available


  10. HEINIMAKI S, Lampinen V, Tamminen K, Hankaniemi MM, et al
    Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
    Virology. 2021;566:89-97.
    PubMed     Abstract available


  11. HU Z, Chen JP, Xu JC, Chen ZY, et al
    A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.
    Virology. 2021;566:56-59.
    PubMed     Abstract available


    November 2021
  12. SHI D, Fan B, Sun B, Zhou J, et al
    LDH nanoparticle adjuvant subunit vaccine induces an effective immune response for porcine epidemic diarrhea virus.
    Virology. 2021;565:58-64.
    PubMed     Abstract available


    October 2021
  13. AHMED SM, Nasr MA, Elshenawy SE, Hussein AE, et al
    BCG vaccination and the risk of COVID 19: A possible correlation.
    Virology. 2021;565:73-81.
    PubMed     Abstract available


    August 2021
  14. MENNE Z, Pliasas VC, Compans RW, Glover S, et al
    Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
    Virology. 2021;562:197-208.
    PubMed     Abstract available


    July 2021
  15. KURT-JONES EA, Dudek TE, Watanabe D, Mandell L, et al
    Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses.
    Virology. 2021;559:165-172.
    PubMed     Abstract available


    May 2021
  16. OH HS, Yoon JW, Lee S, Kim SO, et al
    A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice.
    Virology. 2021;560:124-130.
    PubMed     Abstract available


  17. CASE JB, Winkler ES, Errico JM, Diamond MS, et al
    On the road to ending the COVID-19 pandemic: Are we there yet?
    Virology. 2021;557:70-85.
    PubMed     Abstract available


    March 2021
  18. ABOU EL-FETOUH MS, Hafez MH, El-Attar ER, El-Agamy ME, et al
    Comparative bursal cytokine gene expression and apoptosis in vaccinated chickens following virulent infectious bursal disease virus challenge.
    Virology. 2021;558:126-133.
    PubMed     Abstract available


  19. LEE YH, Lim H, Lee JA, Kim SH, et al
    Optimization of Zika DNA vaccine by delivery systems.
    Virology. 2021;559:10-14.
    PubMed     Abstract available


  20. GAO W, Yue L, Yang T, Li H, et al
    A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.
    Virology. 2021;555:1-9.
    PubMed     Abstract available


    February 2021
  21. NOMURA N, Matsuno K, Shingai M, Ohno M, et al
    Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.
    Virology. 2021;557:55-61.
    PubMed     Abstract available


  22. ABDEL-MONEIM AS, Abdelwhab EM, Memish ZA
    Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
    Virology. 2021;558:1-12.
    PubMed     Abstract available


  23. READ CM, Plante K, Rafael G, Rossi SL, et al
    Designing multivalent immunogens for alphavirus vaccine optimization.
    Virology. 2021 Feb 5. pii: S0042-6822(20)30236.
    PubMed     Abstract available


    December 2020
  24. OJWACH DBA, Madlala P, Gordon M, Ndung'u T, et al
    Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Virology. 2020;554:1-8.
    PubMed     Abstract available


    November 2020
  25. POWELL JD, Abente EJ, Chang J, Souza CK, et al
    Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
    Virology. 2020;553:94-101.
    PubMed     Abstract available


    October 2020
  26. DEVANT JM, Hansman GS
    Structural heterogeneity of a human norovirus vaccine candidate.
    Virology. 2020;553:23-34.
    PubMed     Abstract available


    September 2020
  27. WIECZOREK L, Peachman K, Steers N, Schoen J, et al
    Selection and immune recognition of HIV-1 MPER mimotopes.
    Virology. 2020;550:99-108.
    PubMed     Abstract available


    August 2020
  28. KIM KH, Jung YJ, Lee Y, Park BR, et al
    Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Virology. 2020;550:51-60.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: